PT - JOURNAL ARTICLE AU - Khairulbahri, Muhamad TI - Modeling the COVID-19 transmission in Italy: The roles of asymptomatic cases, social distancing, and lockdowns in the first and the second waves AID - 10.1101/2021.01.08.21249273 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.08.21249273 4099 - http://medrxiv.org/content/early/2021/03/23/2021.01.08.21249273.short 4100 - http://medrxiv.org/content/early/2021/03/23/2021.01.08.21249273.full AB - The SEIR model of COVID-19 is developed to investigate the roles of physical distancing, lockdowns and asymptomatic cases in Italy. In doing so, two types of policies including behavioral measures and lockdown measures are embedded in the model. Compared with existing models, the model successfully reproduces similar multiple observed outputs such as infected and recovered patients in Italy by July 2020. This study concludes that the first policy is important once the number of infected cases is relatively low. However, once the number of infected cases is very high so the society cannot identify infected and disinfected people, the second policy must be applied soon. It is thus this study suggests that relaxed lockdowns lead to the second wave of the COVID-19 around the world. It is hoped that the model can enhance our understanding on the roles of behavioral measures, lockdowns, and undocumented cases, so-called asymptomatic cases, on the COVID-19 flow.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialthis study does not include human or animal trialsFunding StatementThere is no given fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:this paper does not include animal and/or human trialsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesobserved data are available in vdf file in the model